- Country: Chile
- Summary: Drug Agreement of the Isglt2 Group Inhibitors of Sodium-Glucosa Cotransporter Type 2 Program for Preventive Care and Treatment in Aps 2025
- CLT Ref No: 122143255
- Deadline: 09 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CLP 34492759
- Notice Type: Tender
- Document Ref. No.: 690263-6-LE25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The Arauco Health Service requires an agreement for the acquisition of a medicine of the ISGLT2 group (type 2 sodium-glucose collection inhibitors), dapaglifozin or 10 mg packaging, compressed or compressed covered in blister, for the continuity of care program Preventive and treatment in APS 2025, according to technical requirements attached to this tender.
Products or services: medication production services or medicines - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDrug Agreement of the Isglt2 Group Inhibitors of Sodium-Glucosa Cotransporter Type 2 Program for Preventive Care and Treatment in Aps 2025 - Chile Tender
The ARAUCO HEALTH SERVICE, a Government sector organization in Chile, has announced a new tender for Drug Agreement of the Isglt2 Group Inhibitors of Sodium-Glucosa Cotransporter Type 2 Program for Preventive Care and Treatment in Aps 2025. This tender is published on ChileTenders under CLT Ref No: 122143255 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-09.
The estimated tender value is CLP 34492759, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
